Silent Inflammation and Weight
A low-grade, silent inflammation and excess weight can hold each other in place. Belly fat, the gut and lack of sleep fuel it, it disturbs insulin and satiety signals, and that can make losing weight tougher. What the science shows, where it is still open, and in which directions you can steer back.
Many people do everything right and still get nowhere. Eat less, move more, and the weight stays. One explanation that is often overlooked is a silent, low-grade inflammation. Adipose tissue is not a passive storage depot, it is an active organ that releases messengers. These can disturb insulin and satiety signals. This can create a cycle: fat keeps inflammation, inflammation keeps fat. I am writing this text deliberately cautiously. Much of it is well-established cell biology and animal research; in humans the causality is not yet fully clarified. That honesty is part of it.
This spoke belongs to the weight cluster. We look with several lenses at a pattern that standard counselling often leaves unexamined. What is silent inflammation, why is belly fat especially active here, how does inflammation interfere with insulin action, what happens in the brain's satiety centre, what role does the gut play, and in which directions you can steer back. The pure blood sugar side is covered by the spoke on insulin resistance, the hunger hormones by the spoke on leptin and insulin.
What silent inflammation actually is
If you pinch your finger, you know inflammation: red, warm, swollen, painful. That is the loud version, it comes and goes. Silent inflammation is different. It is a weak, persistent activation of the immune system, without those visible signs. You do not notice it directly. It only shows up in lab values, for instance a slightly elevated CRP. Experts call it low-grade chronic inflammation.
Gökhan Hotamisligil, a researcher at Harvard, coined a term of its own for the metabolic variant: metaflammation. What is meant is an inflammation that does not stem from a pathogen but from a too-much: too much fat, too much sugar, too much stimulus for the cells. In his reviews in Nature he describes how closely the immune system and metabolism are intertwined. They share signalling pathways, they influence each other. An imbalance on one side pulls the other along.
Where the immune system and metabolism meet
Mechanistic review Gökhan Hotamisligil describes in two influential reviews in Nature, 2006 and 2017, how immune and metabolic pathways are evolutionarily coupled. His core statement: a chronic, sterile, low-grade inflammation, which he calls metaflammation, sits at the centre of obesity, type 2 diabetes and cardiovascular disease. Unlike the classic defence against infection, it runs quietly and persistently. For you this means: inflammation and metabolism are not separate construction sites, they are two sides of the same cell.
Hotamisligil GS. Nature. 2006;444(7121):860-7. doi:10.1038/nature05485 · and Hotamisligil GS. Nature. 2017;542(7640):177-185. doi:10.1038/nature21363
Inflammation is not your enemy. It is a repair force that is meant to switch on briefly and then subside. It only becomes a problem when it keeps running quietly and permanently. When it comes to weight, the point is therefore not to switch off inflammation, but to reduce the constant stimuli that fuel it.
Belly fat is an active organ, not a silent store
For a long time, adipose tissue was seen as a pantry, a passive depot for surplus energy. That picture is outdated. Adipose tissue produces hormones and messengers. And as its mass grows, it changes its character. Visceral fat in particular, which surrounds the organs deep in the belly, is metabolically active and more inflammation-prone than subcutaneous fat.
A key finding came in 2003. Weisberg and colleagues showed that as fat mass rises, macrophages migrate into adipose tissue. Macrophages are scavenger cells of the immune system. In lean adipose tissue they are barely present; in obese tissue they accumulate, partly in characteristic rings around dying fat cells. And they are the main source of locally produced TNF-alpha, a central inflammatory messenger.
An inflammation crew moves in with the belly fat
In vivo, mouse + human tissue Stuart Weisberg and colleagues examined in 2003 in the Journal of Clinical Investigation the adipose tissue of mice with different body mass and confirmed core findings in human subcutaneous fat. Result: the proportion of macrophages (markers F4/80 and CD68) rose with adipocyte size and body mass. These macrophages were responsible for almost all of the TNF-alpha in the adipose tissue. For you this means: belly fat is not a silent store, an inflammation crew moves in with it. The core findings come from the mouse model, with confirmation in human tissue.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. J Clin Invest. 2003;112(12):1796-808. doi:10.1172/JCI19246 · PMID: 14679176
Not just more immune cells, their character tips over
In vivo, mouse Carey Lumeng and colleagues showed in 2007 in the Journal of Clinical Investigation that a high-fat diet not only increases the number of macrophages in adipose tissue but also shifts their type. In lean mice a rather protective, inflammation-dampening M2 type predominated. Under a high-fat diet the balance tipped toward an inflammatory M1 type that produces TNF-alpha and iNOS. The protective messenger IL-10 could shield fat cells from the TNF-alpha-mediated insulin disturbance. For you: it is not just a question of quantity but of the character of the immune cells. These findings come from the mouse model.
Lumeng CN, Bodzin JL, Saltiel AR. J Clin Invest. 2007;117(1):175-84. doi:10.1172/JCI29881 · PMID: 17200717
In humans, this silent inflammation can be measured indirectly. An often-used marker is CRP. Visser and colleagues showed in 1999 in JAMA, in over 16000 people, that a higher body mass index goes along with higher CRP values. Remarkably, this already held for young adults between 17 and 39 years, and waist circumference was linked to CRP independently of BMI.
Waist circumference and inflammatory value grow together
Cross-sectional, human Marjolein Visser and colleagues analysed in 1999 in JAMA data from 16616 adults in the US NHANES III study. Overweight and obese people clearly more often had elevated CRP values than normal-weight people. In obese women the risk of an elevated CRP was about sixfold higher. The waist-to-hip ratio was linked to CRP independently of BMI, and the association also showed in young adults. For you: inflammatory values rise measurably with waist circumference, often already in young years. CRP is, however, unspecific, it also rises with infections. That is why its interpretation belongs in medical hands.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. JAMA. 1999;282(22):2131-5. doi:10.1001/jama.282.22.2131 · PMID: 10591334
How inflammation can disturb insulin action
Now to the core of the cycle. Insulin is the key that lets sugar out of the blood and into the cells. For this to work, the insulin signal has to be passed along cleanly inside the cell. Inflammatory messengers such as TNF-alpha and interleukin 6 can interfere exactly here. They activate signalling pathways called NF-kappa-B and JNK, which can slow down the insulin relay. The result is a poorer insulin effect, that is insulin resistance.
Picture it like an overloaded reception. Insulin knocks, but the message arrives muffled. The body reacts by releasing more insulin. And high insulin is a signal to store, not to burn. This is how inflammation can contribute to the body preferentially laying down fat while still reporting hunger. Bastard and colleagues summarised in 2006 that a weight loss can reduce macrophage infiltration and thereby lower inflammation again.
Insulin resistance is often understood as a pure sugar problem. Through this lens it is also an inflammation problem. That explains why some people struggle to lose weight even with stable blood sugar values: the silent inflammation can keep running in the background and dampen insulin action.
The satiety centre in the brain
The second level is the brain. In the hypothalamus sits the control centre for hunger and satiety. The hormone leptin reports upward from the fat cells: enough eaten, the stores are full. In excess weight the leptin level is often high, but the message arrives less well. This is called leptin resistance. The body no longer senses satiety properly.
A possible player here too is inflammation. Thaler and colleagues made a surprising observation in 2012. In rats and mice, inflammation in the hypothalamus began as early as 1 to 3 days after the start of a high-fat diet, that is long before the animals gained relevant weight. In imaging, they also found in obese humans signs of gliosis, a kind of scarring, in exactly this brain region.
The inflammation in the satiety centre comes early
In vivo, rat/mouse + human imaging Joshua Thaler and colleagues showed in 2012 in the Journal of Clinical Investigation that a high-fat diet triggered an inflammatory reaction in the hypothalamus in rodents within 1 to 3 days, the control centre for hunger and satiety. This happened before the animals gained substantial weight. With continued diet, inflammation and gliosis returned permanently to the mediobasal hypothalamus. In magnetic resonance imaging, they also found signs of increased gliosis in this region in obese humans. For you: nutrition can irritate the satiety centre before the scale moves. The human evidence is still limited and based on imaging.
Thaler JP, Yi CX, Schur EA, et al. J Clin Invest. 2012;122(1):153-62. doi:10.1172/JCI59660 · PMID: 22201683
Inflammatory pathways can dampen the satiety signal
In vivo, mouse Christiane Koch and colleagues examined in 2014 in the Journal of Neuroendocrinology leptin-deficient mice. A high-fat diet dampened the effect of administered leptin on food intake and blood sugar, that is an acquired leptin resistance. Crucially: when the researchers inhibited the inflammatory pathway JNK, the blood-sugar-lowering effect of leptin returned. For you: inflammation in the brain could, so to speak, mute the satiety signal leptin, and dampening the inflammation could make it audible again. These findings come from the mouse model and are not directly transferable to humans.
Koch CE, Lowe C, Pretz D, Steger J, Williams LM, Tups A. J Neuroendocrinol. 2014;26(2):58-67. doi:10.1111/jne.12131 · PMID: 24382295
The gut as an unexpected inflammation source
Where does the constant stimulus come from that fuels the inflammation? An important source sits in the gut. In the wall of certain gut bacteria there is a substance called lipopolysaccharide, LPS for short. As long as the gut barrier is tight, LPS stays in the gut. If the barrier becomes more permeable, some LPS can reach the blood and activate the immune system there gently but persistently.
Patrice Cani and colleagues coined the term metabolic endotoxemia for this in 2007. In their mouse experiments, a high-fat diet raised the LPS level in the blood two to threefold and shifted the composition of the gut flora. Remarkably: a continuous supply of LPS alone was enough to trigger weight gain and insulin resistance. Mice lacking the matching LPS receptor were largely protected.
When signals from the gut brake the metabolism
In vivo, mouse Patrice Cani and colleagues showed in 2007 in Diabetes that a four-week high-fat diet chronically raised the LPS level in the blood of mice two to threefold. They called this state metabolic endotoxemia. A continuous LPS infusion alone triggered a similar weight gain, fatty liver and insulin resistance as the high-fat diet itself. Mice without the LPS receptor CD14 were protected against most of these effects. For you: a high-fat, fibre-poor diet can shift the gut flora and let inflammatory signals into the blood that brake the metabolism. These findings come from the animal model.
Cani PD, Amar J, Iglesias MA, et al. Diabetes. 2007;56(7):1761-72. doi:10.2337/db06-1491 · PMID: 17456850
A recent review by Engin from 2024 pieces these puzzle parts together: LPS and its receptor TLR4, the so-called NLRP3 inflammasome and cell stress in the adipose tissue interlock. At the same time it urges caution, more on that shortly in the reframe.
„Then I will just take an anti-inflammatory drug and the weight loss will run." Exactly that can backfire. Part of the adipose tissue inflammation has a protective function, for instance as a barrier against gut endotoxins. Engin 2024 describes that a blanket suppression of the inflammation can even paradoxically worsen insulin resistance. Inflammatory pathways in fat cells are partly indispensable for insulin sensitivity. So it is not about switching off, but about the sources.
Four lenses on silent inflammation
From the perspective of Clinical Psychoneuroimmunology it is worthwhile to look at the topic through several lenses. They show why silent inflammation rarely has just one cause.
Immune system
Adipose tissue macrophages and messengers such as TNF-alpha and IL-6 are the main actors. Their character can tip from protective to inflammatory. The immune system here is not a troublemaker but a repair force that falls out of rhythm in continuous operation.
Metabolism
Inflammation and insulin resistance reinforce each other. Disturbed insulin action favours fat storage, more fat keeps more inflammation. A cycle that sustains itself until an adjusting screw breaks it open.
Nervous system
In the hypothalamus, the satiety centre, inflammation can dampen the leptin signals. Stress and the cortisol dynamics also come in here and can favour belly fat and inflammation.
Gut and barrier
The gut flora and the tightness of the gut wall co-decide how many inflammatory signals reach the blood. Fibre, variety on the plate and a healthy gut are therefore more than digestion.
In which directions you can steer back
Now the most important part. What follows from this for everyday life? I deliberately write directions, not recipes. The concrete implementation belongs in an individual consultation. And I separate what is well established from what is plausible but not yet proven.
Established by larger reviews and meta-analyses is the benefit of fibre and unprocessed food for metabolism. Buyken found in 2014 in the American Journal of Clinical Nutrition that a higher fibre intake goes along with lower inflammatory values in observational studies, while the intervention data are weaker. Reynolds showed in 2020 in a meta-analysis that more fibre can act broadly on blood sugar and cardiometabolic markers.
Unprocessed and fibre-rich
Buyken 2014 (AJCN): more fibre goes along with lower hsCRP and IL-6. Reynolds 2020 (PLoS Med): broad metabolic effect. Vegetables, legumes, whole grains feed the gut and can lower the inflammatory load.
Good fats, omega-3
Wei 2020 (meta-analysis, 31 studies): a more favourable ratio of omega-3 to omega-6 can lower TNF-alpha and IL-6, but not reliably CRP. Oily fish, linseed oil, walnuts supply the building blocks.
Sleep as an adjusting screw
Irwin 2016 (Biological Psychiatry, over 50000 people): sleep disturbances go along with higher CRP and IL-6. Poor sleep is an inflammation source of its own, independent of weight.
Weight loss itself
Steckhan 2016 (meta-analysis, Charité Berlin): various dietary approaches could lower CRP, partly depending on weight loss. Bastard 2006: less fat can reduce macrophage infiltration.
Mechanistically plausible, but not yet proven with hard causality in humans, is the direction overall: if you lower the constant stimuli that fuel the silent inflammation, the cycle can loosen. Exercise acts doubly here, it improves insulin sensitivity and has an inflammation-dampening component of its own. Della Guardia described in 2024 how stubbornly the tissues can resist a weight loss, which explains why patience and several levers at once are often more sensible than a single one.
Not the amount alone, the environment decides too
Weight is more than an arithmetic task. It is also a signal from an environment that can be inflamed or calm. Whoever calms this environment, with unprocessed food, good sleep, exercise and a well-tended gut, works at the root, not just at the symptom.
Three levers you can look at this week
Replace one processed meal with an unprocessed one
Not everything at once. Take one meal a day and make it colourful and fibre-rich: vegetables, legumes, a good fat. This feeds the gut and can lower the inflammatory load. The effect comes over weeks, not overnight.
Look at your sleep honestly
Poor sleep is an inflammation source of its own. A fixed wake-up time and a dark, cool bedroom are a simple start. If you sleep poorly over the long term, it is worth addressing this deliberately.
Have your inflammatory values interpreted if needed
A high-sensitivity CRP can be a clue, but it is unspecific and belongs in a medical interpretation, together with waist circumference, blood sugar and lifestyle. It is a signal to take a look, not a verdict on you.
If you do not lose weight despite consistent efforts, if inflammatory values are repeatedly elevated, if blood sugar or blood pressure fall out of range, or if you feel persistently exhausted, have this clarified medically. Weight-loss medications such as GLP-1 agents are prescription-only and belong under medical supervision. This text does not replace a medical examination. If you want not just to read but to work on the causes together, you will find below this article the option to book an appointment.
Frequently asked questions about silent inflammation and weight
What is silent inflammation and what does it have to do with weight?
Silent or low-grade inflammation is a persistent, weak activation of the immune system without the typical signs such as redness or fever. You do not notice it directly, it only shows up in lab values like a slightly elevated CRP. In excess weight, adipose tissue in particular is involved. It is not a passive depot but an active organ that releases inflammatory messengers such as TNF-alpha and interleukin 6 as its mass grows. These can disturb the insulin and leptin signals. Gökhan Hotamisligil coined the term metaflammation for this in Nature. Important: much of this comes from mechanistic and animal studies; in humans the causality is not yet fully established.
How is inflammation linked to insulin resistance?
Inflammatory messengers such as TNF-alpha and interleukin 6 can interfere with the insulin signalling chain. They activate pathways like NF-kappa-B and JNK, which can disturb the relay of the insulin signal inside the cell. The result is a poorer insulin effect, that is insulin resistance. The body then releases more insulin, which can favour fat storage. Hotamisligil describes in Nature how closely the immune system and metabolism are intertwined. Bastard 2006 summarises that weight loss can reduce macrophage infiltration and thereby lower inflammation again. This is mechanistically well founded; the strength of the effect varies from person to person.
Can inflammation in the brain influence hunger and satiety?
There are indications of this. Thaler and colleagues showed in 2012 in the Journal of Clinical Investigation that in rats and mice a high-fat diet triggered inflammation in the hypothalamus within just 1 to 3 days, the control centre for hunger and satiety, and indeed before a relevant weight gain occurred. In imaging, they also found signs of gliosis in this region in obese humans. Koch 2014 showed in mice that a high-fat diet can dampen the effect of the satiety hormone leptin and that inhibiting the inflammatory pathway JNK restored this effect. The human evidence is still limited.
What does metabolic endotoxemia mean and what role does the gut play?
Cani and colleagues coined the term metabolic endotoxemia in 2007 in Diabetes. In their mouse experiments, a high-fat diet raised the amount of lipopolysaccharide (LPS) in the blood two to threefold. LPS is a component of the wall of certain gut bacteria. A continuous infusion of LPS alone was enough to trigger weight gain and insulin resistance. Mice without the matching receptor CD14 were protected. The idea: a high-fat diet can shift the gut flora and make the gut barrier more permeable, so that inflammatory signals reach the blood. This connects nutrition, gut and silent inflammation. These findings come from the animal model.
Does silent inflammation slow down losing weight?
It is plausible but not cleanly proven. Della Guardia 2024 describes how adipose tissue, muscle and the hypothalamus adapt in excess weight so that they counteract weight loss, among other things through inflammation and disturbed insulin and leptin signals. Conversely, weight loss can lower inflammation. Steckhan 2016 found in a meta-analysis at the Charité Berlin that various dietary approaches could lower CRP, whereby the effect partly depended on the weight loss itself. Honestly: inflammation is one of several factors, not the sole culprit.
Which diet can favourably influence silent inflammation?
The data point toward unprocessed, fibre-rich food. Buyken 2014 found in the American Journal of Clinical Nutrition that a higher fibre intake goes along with lower hsCRP and IL-6 values in observational studies, whereby the intervention data are weaker. Reynolds 2020 showed in a meta-analysis that more fibre can act broadly on blood sugar and cardiometabolic markers. For omega-3 fatty acids, Wei 2020 found in a meta-analysis of 31 studies a reduction of TNF-alpha and IL-6, but not reliably of CRP. So it is less about single miracle foods and more about the overall pattern.
Do sleep and stress play a role in silent inflammation?
Yes. Irwin and colleagues pooled in 2016 in Biological Psychiatry more than 70 studies with over 50000 people and found that sleep disturbances and unfavourable sleep duration go along with higher CRP and IL-6 values. Poor sleep is therefore an inflammation source of its own, independent of weight. Chronic stress and the associated cortisol dynamics can also favour inflammation and belly fat. That is why it is worth treating sleep and stress as real adjusting screws.
Should I just take anti-inflammatory drugs to lose weight?
This is not advisable. Engin 2024 points out in a review that adipose tissue inflammation partly has an adaptive function, for instance as a barrier against gut endotoxins. A blanket suppression of the inflammation with medication can even paradoxically worsen insulin resistance, despite possible benefits for weight. Inflammatory pathways in fat cells are partly indispensable for systemic insulin sensitivity. It makes more sense to address the sources: nutrition, exercise, sleep, gut. Medications always belong under medical supervision and do not replace working on the causes.
Connections to other topics
How insulin resistance develops and why it makes losing weight harder. Silent inflammation is one of the motors behind it, which this spoke deepens.
How leptin reports satiety and how leptin resistance develops. Inflammation in the hypothalamus is a possible cause, explained here.
Why the hormonal effect of food counts, not just the calorie count. Unprocessed food can also help favourably via inflammation.
How fibre-rich, unprocessed food fills you up and feeds the gut, a direct lever against silent inflammation.
Why visceral fat is especially metabolically active and inflammation-prone, and which paths can be sensible for reducing it.
Sources and further reading
- Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112(12):1796-808. doi:10.1172/JCI19246 · PMID: 14679176 [In vivo, mouse]
- Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest. 2007;117(1):175-84. doi:10.1172/JCI29881 · PMID: 17200717 [In vivo, mouse]
- Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444(7121):860-7. doi:10.1038/nature05485 · PMID: 17167474 [Mechanism Review]
- Hotamisligil GS. Inflammation, metaflammation and immunometabolic disorders. Nature. 2017;542(7640):177-185. doi:10.1038/nature21363 · PMID: 28179656 [Mechanism Review]
- Bastard JP, Maachi M, Lagathu C, et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17(1):4-12. PMID: 16613757 [Mechanism Review]
- Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999;282(22):2131-5. doi:10.1001/jama.282.22.2131 · PMID: 10591334 [Cohort, Cross-sectional]
- Thaler JP, Yi CX, Schur EA, et al. Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest. 2012;122(1):153-62. doi:10.1172/JCI59660 · PMID: 22201683 [In vivo, rat/mouse]
- Koch CE, Lowe C, Pretz D, Steger J, Williams LM, Tups A. High-fat diet induces leptin resistance in leptin-deficient mice. J Neuroendocrinol. 2014;26(2):58-67. doi:10.1111/jne.12131 · PMID: 24382295 [In vivo, mouse]
- Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56(7):1761-72. doi:10.2337/db06-1491 · PMID: 17456850 [In vivo, mouse]
- Engin A. Reappraisal of Adipose Tissue Inflammation in Obesity. Adv Exp Med Biol. 2024;1460:297-327. doi:10.1007/978-3-031-63657-8_10 · PMID: 39287856 [Mechanism Review]
- Della Guardia L, Shin AC. Obesity-induced tissue alterations resist weight loss: A mechanistic review. Diabetes Obes Metab. 2024;26(8):3045-3057. doi:10.1111/dom.15637 · PMID: 38720199 [Mechanism Review]
- Buyken AE, Goletzke J, Joslowski G, et al. Association between carbohydrate quality and inflammatory markers: systematic review of observational and interventional studies. Am J Clin Nutr. 2014;99(4):813-33. doi:10.3945/ajcn.113.074252 · PMID: 24552752 [Systematic Review]
- Reynolds AN, Akerman AP, Mann J. Dietary fibre and whole grains in diabetes management: Systematic review and meta-analyses. PLoS Med. 2020;17(3):e1003053. doi:10.1371/journal.pmed.1003053 · PMID: 32142510 [Meta-analysis]
- Wei Y, Meng Y, Li N, Wang Q, Chen L. The effects of low-ratio n-6/n-3 PUFA on biomarkers of inflammation: a systematic review and meta-analysis. Food Funct. 2020;12(1):30-40. doi:10.1039/d0fo01976c · PMID: 33232407 [Meta-analysis]
- Steckhan N, Hohmann CD, Kessler C, Dobos G, Michalsen A, Cramer H. Effects of different dietary approaches on inflammatory markers in patients with metabolic syndrome: A systematic review and meta-analysis. Nutrition. 2016;32(3):338-48. doi:10.1016/j.nut.2015.09.010 · PMID: 26706026 [Meta-analysis]
- Irwin MR, Olmstead R, Carroll JE. Sleep Disturbance, Sleep Duration, and Inflammation: A Systematic Review and Meta-Analysis of Cohort Studies and Experimental Sleep Deprivation. Biol Psychiatry. 2016;80(1):40-52. doi:10.1016/j.biopsych.2015.05.014 · PMID: 26140821 [Meta-analysis]